Cargando…

Antiviral agents in the critically ill child

The treatment for most viral infections in children primarily is supportive. Severe viral illnesses and significant secondary complications that require treatment in the intensive care unit may occur in immunocompromised patients and also in infants and children who were previously healthy. Antivira...

Descripción completa

Detalles Bibliográficos
Autor principal: Munoz, Flor M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders Company. 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173155/
https://www.ncbi.nlm.nih.gov/pubmed/32336897
http://dx.doi.org/10.1053/spid.0110035
_version_ 1783524396820856832
author Munoz, Flor M.
author_facet Munoz, Flor M.
author_sort Munoz, Flor M.
collection PubMed
description The treatment for most viral infections in children primarily is supportive. Severe viral illnesses and significant secondary complications that require treatment in the intensive care unit may occur in immunocompromised patients and also in infants and children who were previously healthy. Antiviral agents with specific activity against certain respiratory viruses, herpesviruses, and enteric viruses are available. New drugs are under development, and their use in pediatric patients is a subject of active research. The clinician's knowledge of the mechanisms of action, spectrum of activity, and side effects of these drugs is an important tool for their judicious use in the treatment of the critically ill child. Copyright © 2000 by W.B. Saunders Company
format Online
Article
Text
id pubmed-7173155
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher W.B. Saunders Company.
record_format MEDLINE/PubMed
spelling pubmed-71731552020-04-22 Antiviral agents in the critically ill child Munoz, Flor M. Semin Pediatr Infect Dis Article The treatment for most viral infections in children primarily is supportive. Severe viral illnesses and significant secondary complications that require treatment in the intensive care unit may occur in immunocompromised patients and also in infants and children who were previously healthy. Antiviral agents with specific activity against certain respiratory viruses, herpesviruses, and enteric viruses are available. New drugs are under development, and their use in pediatric patients is a subject of active research. The clinician's knowledge of the mechanisms of action, spectrum of activity, and side effects of these drugs is an important tool for their judicious use in the treatment of the critically ill child. Copyright © 2000 by W.B. Saunders Company W.B. Saunders Company. 2000-01 2005-11-02 /pmc/articles/PMC7173155/ /pubmed/32336897 http://dx.doi.org/10.1053/spid.0110035 Text en Copyright © 2000 W.B. Saunders Company. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Munoz, Flor M.
Antiviral agents in the critically ill child
title Antiviral agents in the critically ill child
title_full Antiviral agents in the critically ill child
title_fullStr Antiviral agents in the critically ill child
title_full_unstemmed Antiviral agents in the critically ill child
title_short Antiviral agents in the critically ill child
title_sort antiviral agents in the critically ill child
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173155/
https://www.ncbi.nlm.nih.gov/pubmed/32336897
http://dx.doi.org/10.1053/spid.0110035
work_keys_str_mv AT munozflorm antiviralagentsinthecriticallyillchild